EC1456
Asset
Folate receptor-targeted tubulysin conjugate
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- FOLR1
- 1
- Indication
- 166
- Trials
- 1
- Developer
Indications
1Ovary cancer
Phase 1, Completed, NCT03011320, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials166
- Evidence for its targets3
- Competitors4
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.